Saral Gyan 15% @ 90 Days - Jan 2014
Upcoming SlideShare
Loading in...5
×
 

Saral Gyan 15% @ 90 Days - Jan 2014

on

  • 1,034 views

 

Statistics

Views

Total Views
1,034
Views on SlideShare
1,028
Embed Views
6

Actions

Likes
0
Downloads
6
Comments
1

1 Embed 6

http://www.slideee.com 6

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Saral Gyan 15% @ 90 Days - Jan 2014 Saral Gyan 15% @ 90 Days - Jan 2014 Document Transcript

  • BUY TO SELL STOCKS FOR SHORT TERM GAINS 02nd January 2014 PANACEA BIOTEC BUY POTENTIAL UPSIDE: 18.3% CURRENT MARKET PRICE: 102.30 TARGET PRICE: 121.00 BSE Code 531349 Market Cap (Crores) 626.60 NSE Code PANACEABIO P/E 0 Book Value 91.63 EPS -42.81 Face Value 1 Dividend Yield % - STOCK RECOMMENDATION
  • 15% @ 90 DAYS – JAN 2014 - 2 - SARAL GYAN CAPITAL SERVICES Comparative Chart (Last 1 Year) Panacea Biotec & Nifty: Nifty: 3.5% Panacea Biotec: -9.7% Stock Resistance and Support: 1st Resistance – 110 1st Support – 98 2nd Resistance – 122 2nd Support – 85
  • 15% @ 90 DAYS – JAN 2014 - 3 - SARAL GYAN CAPITAL SERVICES Financials at a Glance: Quarterly Results of Panacea Biotec (Rs. In Millions) Particulars Sep 2013 Jun 2013 Mar 2013 Dec 2012 Audited / UnAudited UA UA UA UA Net Sales 1100.90 1176.30 1903.60 1841.00 Total Expenditure 1112.40 1277.20 2098.00 2003.90 PBIDT(Excl OI) -11.50 -100.90 -194.40 -162.90 Other Income 2.00 2.50 39.80 25.70 OperatingProfit -9.50 -98.40 -154.60 -137.20 Interest 368.20 321.20 357.00 269.80 Exceptional Items 0 0 -105.70 0 PBDT -377.70 -419.60 -617.30 -407.00 Depreciation 185.00 189.60 210.20 215.80 ProfitBeforeTax -562.70 -609.20 -827.50 -622.80 Tax 0 0 0 0 Provisionsand contingencies 0 0 0 0 ProfitAfter Tax -562.70 -609.20 -827.50 -622.80 Extraordinary Items 0 0 0 0 Prior Period Expenses 0 0 0 0 Other Adjustments 0 0 0 0 Net Profit -562.70 -609.20 -827.50 -622.80 Equity Capital 61.30 61.30 61.30 61.30 FaceValue(INRS) 1 1 1 1 Reserves Calculated EPS -9.18 -9.94 -13.50 -10.16 Calculated EPS (Annualised) -36.72 -39.75 -54.00 -40.64 No of PublicShareHoldings 15427192.00 15427192.00 15427192.00 15427192.00 % of Public ShareHoldings 25.19 25.19 25.19 25.19
  • 15% @ 90 DAYS – JAN 2014 - 4 - SARAL GYAN CAPITAL SERVICES Basis of Recommendation: i) Technical Analysis Disclaimer: Important Notice: Saral Gyan Capital Services is an Independent Equity Research Company. © SARAL GYAN CAPITAL SERVICES This Service is provided on an "As Is" basis by saral gyan capital services. Saral gyan capital services and its affiliates disclaim any warranty of any kind, imputed by the laws of any jurisdiction, whether express or implied, as to any matter whatsoever relating to the Service, including without limitation the implied warranties of merchantability, fitness for a particular purpose. Neither saral gyan capital services nor its affiliates will be responsible for any loss or liability incurred to the user as a consequence of his or any other person on his behalf taking any investment decisions based on the above recommendation. Use of the Service is at any persons, including a Customer's, own risk. The investments discussed or recommended through this service may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advisors as they believe necessary. Information herein is believed to be reliable but saral gyan capital services and its affiliates do not warrant its completeness or accuracy. The service should not be construed to be an advertisement for solicitation for buying or selling of any securities.